Alzheimers Dement

1. ISLAM T, Kvartsberg H, Sehrawat A, Kac PR, et al
   Novel ultrasensitive immunoassay for the selective quantification of tau oligomers and related soluble aggregates.
   Alzheimers Dement. 2024;20:2894-2905.
   

   >> Share

   
   
2. KATSUMATA Y, Fardo DW, Shade LMP, Wu X, et al
   Genetic associations with dementia-related proteinopathy: Application of item response theory.
   Alzheimers Dement. 2024;20:2906-2921.
   

   >> Share

   
   
3. DATTA D, Perone I, Wijegunawardana D, Liang F, et al
   Nanoscale imaging of pT217-tau in aged rhesus macaque entorhinal and dorsolateral prefrontal cortex: Evidence of interneuronal trafficking and early-stage neurodegeneration.
   Alzheimers Dement. 2024;20:2843-2860.
   

   >> Share

   
   
4. DESIMONE JC, Wang WE, Loewenstein DA, Duara R, et al
   Diffusion MRI relates to plasma Abeta42/40 in PET negative participants without dementia.
   Alzheimers Dement. 2024;20:2830-2842.
   

   >> Share

   
   
5. ARMSTRONG MJ, LaBarre B, Sovich K, Maixner SM, et al
   Patient- and proxy-reported quality of life in advanced dementia with Lewy bodies.
   Alzheimers Dement. 2024;20:2719-2730.
   

   >> Share

   
   
6. JOSEPH-MATHURIN N, Feldman RL, Lu R, Shirzadi Z, et al
   Presenilin-1 mutation position influences amyloidosis, small vessel disease, and dementia with disease stage.
   Alzheimers Dement. 2024;20:2680-2697.
   

   >> Share

   
   
7. YOUNG CB, Smith V, Karjadi C, Grogan SM, et al
   Speech patterns during memory recall relates to early tau burden across adulthood.
   Alzheimers Dement. 2024;20:2552-2563.
   

   >> Share

   
   
8. FONSECA CS, Baker SL, Dobyns L, Janabi M, et al
   Tau accumulation and atrophy predict amyloid independent cognitive decline in aging.
   Alzheimers Dement. 2024;20:2526-2537.
   

   >> Share

   
   
9. 
   Critical Alzheimer's disease legislation advances in Congress.
   Alzheimers Dement. 2024;20:3141-3142.
   

   >> Share

   
   
10. SAADMAAN G, Dalmasso MC, Ramirez A, Hiltunen M, et al
    Alzheimer's disease genetic risk score and neuroimaging in the FINGER lifestyle trial.
    Alzheimers Dement. 2024 Apr 22. doi: 10.1002/alz.13843.
    

    >> Share

    
    
11. ZHANG J, Chen H, Wang J, Huang Q, et al
    Linking white matter hyperintensities to regional cortical thinning, amyloid deposition, and synaptic density loss in Alzheimer's disease.
    Alzheimers Dement. 2024 Apr 22. doi: 10.1002/alz.13845.
    

    >> Share

    
    
12. CHEN KL, Wang MY, Wu J, Zuo CT, et al
    Incremental value of amyloid PET in a tertiary memory clinic setting in China.
    Alzheimers Dement. 2024;20:2516-2525.
    

    >> Share

    
    
13. RITCHIE M, Salazar CR, Gillen DL, Grill JD, et al
    Post-disclosure distress among racial and ethnic groups in a preclinical AD trial.
    Alzheimers Dement. 2024;20:2508-2515.
    

    >> Share

    
    
14. KLEIN EG, Schroeder K, Wessels AM, Phipps A, et al
    How donanemab data address the coverage with evidence development questions.
    Alzheimers Dement. 2024;20:3127-3140.
    

    >> Share

    
    
15. EDISON P
    Astroglial activation: Current concepts and future directions.
    Alzheimers Dement. 2024;20:3034-3053.
    

    >> Share

    
    
16. ALBRECHT JS, Scherf A, Ryan KA, Falvey JR, et al
    Impact of dementia and socioeconomic disadvantage on days at home after traumatic brain injury among older Medicare beneficiaries: A cohort study.
    Alzheimers Dement. 2024;20:2364-2372.
    

    >> Share

    
    
17. HINTON L, Tran D, Peak K, Meyer OL, et al
    Mapping racial and ethnic healthcare disparities for persons living with dementia: A scoping review.
    Alzheimers Dement. 2024;20:3000-3020.
    

    >> Share

    
    
18. LEVIN J, Baiardi S, Quadalti C, Rossi M, et al
    alpha-Synuclein seed amplification assay detects Lewy body co-pathology in autosomal dominant Alzheimer's disease late in the disease course and dependent on Lewy pathology burden.
    Alzheimers Dement. 2024 Apr 26. doi: 10.1002/alz.13818.
    

    >> Share

    
    

    
    BMC Geriatr

19. LI T, Hu Z, Qiao L, Wu Y, et al
    Chronic kidney disease and cognitive performance: NHANES 2011-2014.
    BMC Geriatr. 2024;24:351.
    

    >> Share

    
    

    
    Brain

20. BARBOUR AJ, Gourmaud S, Lancaster E, Li X, et al
    Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice.
    Brain. 2024 Apr 25:awae126. doi: 10.1093.
    

    >> Share

    
    
21. CODY KA, Langhough RE, Zammit MD, Clark L, et al
    Characterizing brain tau and cognitive decline along the amyloid timeline in Alzheimer's disease.
    Brain. 2024 Apr 26:awae116. doi: 10.1093.
    

    >> Share

    
    

    
    Curr Alzheimer Res

22. HE X, Selesnick I, Zhu M
    Research Progress of Eye Movement Analyses and its Detection Algorithms in Alzheimer's Disease.
    Curr Alzheimer Res. 2024 Apr 24. doi: 10.2174/0115672050300564240416074025.
    

    >> Share

    
    

    
    J Alzheimers Dis

23. SYED RA, Hayat M, Qaiser H, Uzair M, et al
    Aging-Related Protein Alterations in the Brain.
    J Alzheimers Dis. 2024;99.
    

    >> Share

    
    
24. CALDERON-GARCIDUENAS L, Ayala A, Mukherjee PS
    2024 United States Elections: Air Pollution, Neurodegeneration, Neuropsychiatric, and Neurodevelopmental Disorders. Who Cares?
    J Alzheimers Dis. 2024;98:1277-1282.
    

    >> Share

    
    
25. HOJJATI SH, Chiang GC, Butler TA, de Leon M, et al
    Remote Associations Between Tau and Cortical Amyloid-beta Are Stage-Dependent.
    J Alzheimers Dis. 2024;98:1467-1482.
    

    >> Share

    
    
26. GALANKIN TL, Bespalov AY, Moebius HY
    Clusterization of Behavioral and Psychological Symptoms of Dementia as Assessed by Neuropsychiatric Inventory: A Case Against the Use of Principal Component Analysis.
    J Alzheimers Dis. 2024;98:1483-1491.
    

    >> Share

    
    
27. 
    Erratum to: Loss in PKC Epsilon Causes Downregulation of MnSOD and BDNF Expression in Neurons of Alzheimer's Disease Hippocampus.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-249008.
    

    >> Share

    
    
28. UM YH, Wang SM, Kang DW, Kim S, et al
    Impact of Apolipoprotein E4 on the Locus Coeruleus Functional Connectivity in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240065.
    

    >> Share

    
    
29. HUANG Z
    Evidence that Alzheimer's Disease Is a Disease of Competitive Synaptic Plasticity Gone Awry.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-240042.
    

    >> Share

    
    
30. ELGHANAM Y, Purja S, Kim EY
    Biomarkers as Endpoints in Clinical Trials for Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-240008.
    

    >> Share

    
    
31. LIU M, Ma N, Yang X, Sun M, et al
    The Association of Circulating Glucagon-Like Peptide-1 with Cognitive Functions and Biomarkers in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 25. doi: 10.3233/JAD-240001.
    

    >> Share

    
    
32. DURAN T, Gaussoin SA, Latham LA, Rundle MM, et al
    Examining a Preclinical Alzheimer's Cognitive Composite for Telehealth Administration for Reliability Between In-Person and Remote Cognitive Testing with Neuroimaging Biomarkers.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231435.
    

    >> Share

    
    
33. DUFF K, Hammers DB, Koppelmans V, King JB, et al
    Short-Term Practice Effects on Cognitive Tests Across the Late Life Cognitive Spectrum and How They Compare to Biomarkers of Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231392.
    

    >> Share

    
    
34. CETINSOY O, Anyanwu I, Krishnanand H, Natarajan G, et al
    Gene Association Study of the Urokinase Plasminogen Activator and Its Receptor Gene in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-231383.
    

    >> Share

    
    
35. GARCIA-CARLOS CA, Basurto-Islas G, Perry G, Mondragon-Rodriguez S, et al
    Meta-Analysis in Transgenic Alzheimer's Disease Mouse Models Reveals Opposite Brain Network Effects of Amyloid-beta and Phosphorylated Tau Proteins.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231365.
    

    >> Share

    
    
36. BUTLER T, Wang X, Chiang G, Xi K, et al
    Reduction in Constitutively Activated Auditory Brainstem Microglia in Aging and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231312.
    

    >> Share

    
    
37. CHEN Y, Su Y, Wu J, Chen K, et al
    Combining Blood-Based Biomarkers and Structural MRI Measurements to Distinguish Persons with and without Significant Amyloid Plaques.
    J Alzheimers Dis. 2024;98:1415-1426.
    

    >> Share

    
    
38. JANBEK J, Laursen TM, Frimodt-Moller N, Magyari M, et al
    Risk of Major Types of Dementias Following Hospital-Diagnosed Infections and Autoimmune Diseases.
    J Alzheimers Dis. 2024;98:1503-1514.
    

    >> Share

    
    
39. KIM D, Jamrasi P, Li X, Ahn S, et al
    Effects of Exercise on Urinary AD7c-NTP (Alzheimer-Associated Neuronal Thread Protein) Levels and Cognitive Function Among Active Korean Elderly: A Randomized Controlled Trial.
    J Alzheimers Dis. 2024 Apr 20. doi: 10.3233/JAD-230946.
    

    >> Share

    
    
40. NGO S, Jackson AJ, Manivannan M, Young JC, et al
    Real World Financial Mismanagement in Alzheimer's Disease, Frontotemporal Dementia, and Primary Progressive Aphasia.
    J Alzheimers Dis. 2024 Apr 24. doi: 10.3233/JAD-231021.
    

    >> Share

    
    
41. MEMON A, Moore JA, Kang C, Ismail Z, et al
    Visual Functions Are Associated with Biomarker Changes in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 26. doi: 10.3233/JAD-231084.
    

    >> Share

    
    
42. KIM M, Song YS, Han K, Bae YJ, et al
    Impaired Glymphatic Flow on Diffusion Tensor MRI as a Marker of Neurodegeneration in Alzheimer's Disease: Correlation with Gray Matter Volume Loss and Cognitive Decline Independent of Cerebral Amyloid Deposition.
    J Alzheimers Dis. 2024 Apr 19. doi: 10.3233/JAD-231131.
    

    >> Share

    
    

    
    J Biol Chem

43. SHIPPY DC, Oliai SF, Ulland TK
    Zinc utilization by microglia in Alzheimer's disease.
    J Biol Chem. 2024 Apr 20:107306. doi: 10.1016/j.jbc.2024.107306.
    

    >> Share

    
    

    
    J Neurol

44. WANG S, Zheng X, Huang J, Liu J, et al
    Sleep characteristics and risk of Alzheimer's disease: a systematic review and meta-analysis of longitudinal studies.
    J Neurol. 2024 Apr 24. doi: 10.1007/s00415-024-12380.
    

    >> Share

    
    

    
    J Neurol Neurosurg Psychiatry

45. KOROLOGOU-LINDEN R, Xu B, Coulthard E, Walton E, et al
    Genetics impact risk of Alzheimer's disease through mechanisms modulating structural brain morphology in late life.
    J Neurol Neurosurg Psychiatry. 2024 Apr 25:jnnp-2023-332969.
    

    >> Share

    
    

    
    J Neurosci

46. ZHANG A, Wengler K, Zhu X, Horga G, et al
    Altered hierarchical gradients of intrinsic neural timescales in mild cognitive impairment and Alzheimer's disease.
    J Neurosci. 2024 Apr 24:e2024232024. doi: 10.1523/JNEUROSCI.2024-23.2024.
    

    >> Share

    
    

    
    Nature

47. WEN X, Luo Z, Zhao W, Calandrelli R, et al
    Single-cell multiplex chromatin and RNA interactions in ageing human brain.
    Nature. 2024;628:648-656.
    

    >> Share

    
    

    
    Neurobiol Dis

48. TONG B, Ba Y, Li Z, Yang C, et al
    Targeting dysregulated lipid metabolism for the treatment of Alzheimer's disease and Parkinson's disease: Current advancements and future prospects.
    Neurobiol Dis. 2024 Apr 18:106505. doi: 10.1016/j.nbd.2024.106505.
    

    >> Share

    
    
49. LEMCHE E, Killick R, Mitchell J, Caton PW, et al
    Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
    Neurobiol Dis. 2024;196:106485.
    

    >> Share

    
    

    
    Neuropsychology

50. KORTHAUER LE, Gemelli ZT, O'Shea D, Ott BR, et al
    Association between neuropsychological assessment and amyloid status in a clinical setting.
    Neuropsychology. 2024;38:337-346.
    

    >> Share

    
    
51. DELAGE E, Rouleau I, Akzam-Ouellette MA, Roy-Cote F, et al
    An examination of semantic performance in mild cognitive impairment progressors and nonprogressors.
    Neuropsychology. 2024;38:309-321.
    

    >> Share

    
    

    
    PLoS Biol

52. WU D, Sun JK, Chow KH
    Neuronal cell cycle reentry events in the aging brain are more prevalent in neurodegeneration and lead to cellular senescence.
    PLoS Biol. 2024;22:e3002559.
    

    >> Share

    
    

    
    PLoS One

53. LACEY C, Paterson T, Gawryluk JR
    Impact of APOE-epsilon alleles on brain structure and cognitive function in healthy older adults: A VBM and DTI replication study.
    PLoS One. 2024;19:e0292576.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share